Annual long term liabilities:
$1.03B-$522.00M(-33.53%)Summary
- As of today (May 21, 2025), MRNA annual total long term liabilities is $1.03 billion, with the most recent change of -$522.00 million (-33.53%) on December 31, 2024.
- During the last 3 years, MRNA annual long term liabilities has fallen by -$361.00 million (-25.86%).
- MRNA annual long term liabilities is now -42.88% below its all-time high of $1.81 billion, reached on December 31, 2022.
Performance
MRNA Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$1.03B-$1.00M(-0.10%)Summary
- As of today (May 21, 2025), MRNA quarterly total long term liabilities is $1.03 billion, with the most recent change of -$1.00 million (-0.10%) on March 31, 2025.
- Over the past year, MRNA quarterly long term liabilities has dropped by -$498.00 million (-32.51%).
- MRNA quarterly long term liabilities is now -42.94% below its all-time high of $1.81 billion, reached on December 31, 2022.
Performance
MRNA quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MRNA Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.5% | -32.5% |
| 3 y3 years | -25.9% | -20.2% |
| 5 y5 years | +281.2% | +254.0% |
MRNA Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.9% | at low | -42.9% | at low |
| 5 y | 5-year | -42.9% | +281.2% | -42.9% | +254.0% |
| alltime | all time | -42.9% | >+9999.0% | -42.9% | >+9999.0% |
MRNA Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.03B(-0.1%) |
| Dec 2024 | $1.03B(-33.5%) | $1.03B(-38.2%) |
| Sep 2024 | - | $1.68B(+4.4%) |
| Jun 2024 | - | $1.60B(+4.8%) |
| Mar 2024 | - | $1.53B(-1.6%) |
| Dec 2023 | $1.56B(-14.1%) | $1.56B(-3.3%) |
| Sep 2023 | - | $1.61B(-11.1%) |
| Jun 2023 | - | $1.81B(+2.8%) |
| Mar 2023 | - | $1.76B(-2.7%) |
| Dec 2022 | $1.81B(+29.8%) | $1.81B(+44.2%) |
| Sep 2022 | - | $1.26B(+0.9%) |
| Jun 2022 | - | $1.25B(-3.9%) |
| Mar 2022 | - | $1.30B(-7.2%) |
| Dec 2021 | $1.40B(+260.7%) | $1.40B(+65.8%) |
| Sep 2021 | - | $842.00M(+38.3%) |
| Jun 2021 | - | $609.00M(+46.7%) |
| Mar 2021 | - | $415.00M(+7.2%) |
| Dec 2020 | $387.00M(+42.5%) | $387.00M(-7.3%) |
| Sep 2020 | - | $417.51M(+10.6%) |
| Jun 2020 | - | $377.47M(+29.2%) |
| Mar 2020 | - | $292.08M(+7.6%) |
| Dec 2019 | $271.50M(+29.8%) | $271.50M(+42.0%) |
| Sep 2019 | - | $191.25M(+3.5%) |
| Jun 2019 | - | $184.74M(-8.1%) |
| Mar 2019 | - | $201.01M(-3.9%) |
| Dec 2018 | $209.10M(-21.9%) | $209.10M(-7.6%) |
| Sep 2018 | - | $226.31M(-15.5%) |
| Dec 2017 | $267.73M(-35.1%) | $267.73M(>+9900.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $412.51M(+8325.4%) | - |
| Dec 2016 | - | $0.00(-100.0%) |
| Sep 2016 | - | $2.47M(-16.7%) |
| Jun 2016 | - | $2.96M(+4.3%) |
| Mar 2016 | - | $2.84M(-41.9%) |
| Dec 2015 | $4.90M(-58.0%) | $4.90M(-18.8%) |
| Sep 2015 | - | $6.03M(-23.9%) |
| Jun 2015 | - | $7.93M(-19.4%) |
| Mar 2015 | - | $9.84M(-15.5%) |
| Dec 2014 | $11.64M(+35.6%) | $11.64M(-34.8%) |
| Sep 2014 | - | $17.86M(+44.0%) |
| Jun 2014 | - | $12.41M(-26.8%) |
| Mar 2014 | - | $16.95M(+97.3%) |
| Dec 2013 | $8.59M(+15.2%) | $8.59M(+31.8%) |
| Sep 2013 | - | $6.51M(+18.9%) |
| Jun 2013 | - | $5.48M(-3.7%) |
| Mar 2013 | - | $5.69M(-23.7%) |
| Dec 2012 | $7.45M(+5.4%) | $7.45M(+54.6%) |
| Sep 2012 | - | $4.82M(-14.4%) |
| Jun 2012 | - | $5.63M(-33.0%) |
| Mar 2012 | - | $8.41M(+18.9%) |
| Dec 2011 | $7.07M(+17.9%) | $7.07M(-11.3%) |
| Sep 2011 | - | $7.98M(-11.1%) |
| Jun 2011 | - | $8.98M(+154.7%) |
| Mar 2011 | - | $3.52M(-41.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $6.00M(-33.2%) | $6.00M(-33.2%) |
| Sep 2010 | - | $8.98M(-21.9%) |
| Jun 2010 | - | $11.51M(-10.2%) |
| Mar 2010 | - | $12.81M(+42.6%) |
| Dec 2009 | $8.98M(+132.1%) | $8.98M(-30.7%) |
| Sep 2009 | - | $12.97M(-1.7%) |
| Jun 2009 | - | $13.19M(+213.4%) |
| Mar 2009 | - | $4.21M(+8.7%) |
| Dec 2008 | $3.87M(-56.1%) | $3.87M(-22.9%) |
| Sep 2008 | - | $5.03M(-16.7%) |
| Jun 2008 | - | $6.03M(-20.5%) |
| Mar 2008 | - | $7.58M(-14.1%) |
| Dec 2007 | $8.83M(-44.0%) | $8.83M(-35.5%) |
| Sep 2007 | - | $13.69M(-7.5%) |
| Jun 2007 | - | $14.79M(-2.4%) |
| Mar 2007 | - | $15.16M(-3.9%) |
| Dec 2006 | $15.77M(+92.1%) | $15.77M(+29.3%) |
| Sep 2006 | - | $12.19M(+12.5%) |
| Jun 2006 | - | $10.84M(+2.0%) |
| Mar 2006 | - | $10.63M(+29.5%) |
| Dec 2005 | $8.21M(+41.9%) | $8.21M(+29.5%) |
| Sep 2005 | - | $6.34M(+9.8%) |
| Jun 2005 | - | $5.77M(+4.4%) |
| Mar 2005 | - | $5.53M(-4.4%) |
| Dec 2004 | $5.78M(+167.3%) | $5.78M(-5.2%) |
| Sep 2004 | - | $6.10M(+158.3%) |
| Jun 2004 | - | $2.36M(+12.4%) |
| Mar 2004 | - | $2.10M(-2.9%) |
| Dec 2003 | $2.16M(-70.5%) | $2.16M(+32.1%) |
| Sep 2003 | - | $1.64M(+8.8%) |
| Jun 2003 | - | $1.50M(-87.0%) |
| Mar 2003 | - | $11.55M(+57.3%) |
| Dec 2002 | $7.34M(>+9900.0%) | $7.34M(+16.3%) |
| Sep 2002 | - | $6.31M(+106.7%) |
| Jun 2002 | - | $3.06M(+76.0%) |
| Mar 2002 | - | $1.74M(+5686.7%) |
| Dec 2001 | $30.00K(-3100.0%) | $30.00K(-3100.0%) |
| Dec 1999 | -$1000.00(-101.0%) | -$1000.00(-101.0%) |
| Sep 1999 | - | $100.00K(-200.0%) |
| Jun 1998 | - | -$100.00K(-200.0%) |
| Dec 1997 | $100.00K(0.0%) | $100.00K(0.0%) |
| Sep 1997 | - | $100.00K(0.0%) |
| Jun 1997 | - | $100.00K(-200.0%) |
| Sep 1996 | - | -$100.00K(-200.0%) |
| Jun 1996 | $100.00K(0.0%) | $100.00K(-50.0%) |
| Mar 1996 | - | $200.00K(0.0%) |
| Dec 1995 | - | $200.00K(0.0%) |
| Sep 1995 | - | $200.00K(+100.0%) |
| Jun 1995 | $100.00K(-80.0%) | $100.00K(-66.7%) |
| Mar 1995 | - | $300.00K(0.0%) |
| Dec 1994 | - | $300.00K(0.0%) |
| Sep 1994 | - | $300.00K(-40.0%) |
| Jun 1994 | $500.00K | $500.00K(0.0%) |
| Mar 1994 | - | $500.00K(0.0%) |
| Dec 1993 | - | $500.00K(-16.7%) |
| Sep 1993 | - | $600.00K |
FAQ
- What is Moderna annual total long term liabilities?
- What is the all time high annual long term liabilities for Moderna?
- What is Moderna annual long term liabilities year-on-year change?
- What is Moderna quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Moderna?
- What is Moderna quarterly long term liabilities year-on-year change?
What is Moderna annual total long term liabilities?
The current annual long term liabilities of MRNA is $1.03B
What is the all time high annual long term liabilities for Moderna?
Moderna all-time high annual total long term liabilities is $1.81B
What is Moderna annual long term liabilities year-on-year change?
Over the past year, MRNA annual total long term liabilities has changed by -$522.00M (-33.53%)
What is Moderna quarterly total long term liabilities?
The current quarterly long term liabilities of MRNA is $1.03B
What is the all time high quarterly long term liabilities for Moderna?
Moderna all-time high quarterly total long term liabilities is $1.81B
What is Moderna quarterly long term liabilities year-on-year change?
Over the past year, MRNA quarterly total long term liabilities has changed by -$498.00M (-32.51%)